Bicara Therapeutics Inc. · NASDAQ:BCAX

Vestal Point Capital, LP reported a 5.10% stake in Bicara Therapeutics Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Vestal Point Capital, LP reported a 5.10% stake in Bicara Therapeutics Inc., 2,768,975 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
5.10%
Shares
2,768,975
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Vestal Point Capital, LP5.10%2,768,975
Ryan Wilder5.10%2,768,975

Source

View original at SEC

Related